肝硬化门静脉高压的介入治疗进展

张雪; 胥莹; 邹松龙; 吴杰芳; 孟淑慧

doi:10.3969/j.issn.1001-5256.2019.10.039

肝硬化门静脉高压的介入治疗进展

DOI: 10.3969/j.issn.1001-5256.2019.10.039

昆明医科大学附属第二医院消化内科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 1082
- HTML全文浏览量: 10
- PDF下载量: 278
- 被引次数: 0
出版历程
- 收稿日期: 2019-05-29
- 出版日期: 2019-10-20

Research advances in interventional treatment of cirrhotic portal hypertension

Department of Gastroenterology,The Second Affiliated Hospital of Kunming Medical University

摘要

摘要: 门静脉高压是肝硬化失代偿期的主要临床表现之一。肝硬化门静脉高压导致的诸如食管胃底静脉曲张出血、脾功能亢进、难治性腹水等一系列并发症严重威胁人类健康。自20世纪70年代放射介入技术开始应用于门静脉高压症的治疗以来,通过近几十年的发展,其技术不断成熟,更多的改良及新技术被应用于临床,其有效性和安全性也得到越来越多的认证。归纳了近年来国内外的相关文献,对介入技术在肝硬化门静脉高压患者中的临床应用进展作一综述,以指导肝硬化门静脉高压患者的治疗。
- 肝硬化 /
- 高血压,门静脉 /
- 最小侵入性外科手术
Abstract: Portal hypertension is one of the main clinical manifestations of decompensated cirrhosis. A series of complications due to cirrhotic portal hypertension,such as esophagogastric variceal bleeding,hypersplenism,and intractable ascites,greatly threaten human health.Since the application of the radiological interventional technique in the treatment of portal hypertension in the 1970 s,this technique has gradually become mature over the past few decades,and more improvements and new techniques have been applied in clinical practice,with an increasing number of evidence for its efficacy and safety. This article summarizes related articles in China and foreign countries and reviews the clinical application of interventional techniques in patients with cirrhotic portal hypertension,in order to guide the treatment of patients with cirrhotic portal hypertension.
- liver cirrhosis /
- hypertension,portal /
- minimally invasive surgical procedures

HTML全文

参考文献(34)

[1] PIMPIN L,CORTEZ-PINTO H,NEGRO F,et al. Burden of liver disease in Europe:Epidemiology and analysis of risk factors to identify prevention policies[J]. J Hepatol,2018,69(3):718-735.

[2] BLEI AT. Portal hypertension and its complications[J]. Gastroenterology,2010,45(Suppl 1):1715-1728.

[3] SPIGOS DG,JONASSON O,MOZES M. Partial splenic embolization in the treatment of hypersplenism[J]. AJR Am J Roentgenol,1979,132(5):777-782.

[4] DUBOIS B,MOBLEY D,CHICK JFB,et al. Efficacy and safety of partial splenic embolization for hypersplenism in preand post-liver transplant patients:A 16-year comparative analysis[J]. Clin imaging,2019,54:71-77.

[5] ZHU K,MENG X,QIAN J,et al. Partial splenic embolization for hypersplenism in cirrhosis:A long-term outcome in 62 patients[J]. Dig Liver Dis,2009,41(6):411-416.

[6] YOSHIDA H,MAMADA Y,TANIAI N,et al. Partial splenic embolization[J]. Hepatol Res,2010,38(3):225-233.

[7] MARTINS GLP,BERNARDES JPG,ROVELLA MS,et al. Radiofrequency ablation for treatment of hypersplenism:A feasible therapeutic option[J]. World J Gastroenterol,2015,21(20):6391-6397.

[8] XIANG WJ,FEI G,YAN M,et al. Percutaneous microwave ablation in the spleen for treatment of hypersplenism in cirrhosis patients[J]. Dig Dis Sci,2016,61(1):287-292.

[9] LIU Q,MA K,SONG Y,et al. Two-year follow-up of splenic radiofrequency ablation in patients with cirrhotic hypersplenism:Does increased hepatic arterial flow induce liver regeneration?[J]. Surgery,2008,143(4):509-518.

[10] ZHOU RZ,XIE FP,CHEN L. Analysis on risk factors of patients with upper gastrointestinal bleeding in cirrhosis[J]. J Clin Exp Med,2019,18(12):1280-1283.(in Chinese)周仁正,谢发平,陈璐.肝硬化合并上消化道出血患者的危险因素分析[J].临床和实验医学杂志,2019,18(12):1280-1283.

[11] KALVA SP,SALAZAR GM,WALKER TG. Transjugular intrahepatic portosystemic shunt for acute variceal hemorrhage[J].Tech Vasc Interv Radiol,2009,12(2):92-101.

[12] DING ZF,YIN SW. Application of Viatorr covered stent in transjugular intrahepatic portosystemic shunt[J]. J Clin Hepatol,2018,34(5):1107-1110.(in Chinese)丁智锋,殷世武. Viatorr覆膜支架在经颈静脉肝内门体分流术中的应用现状[J].临床肝胆病杂志,2018,34(5):1107-1110.

[13] Chinese Medical Association Digestive Diseases Branch Digestive Intervention Group. Consensus on transjugular intrahepatic portosystemic shunt for treatment of cirrhotic portal hypertension[J]. J Clin Hepatol,2014,30(3):210-213.(in Chinese)中华医学会消化病学分会消化介入学组.经颈静脉肝内门体静脉分流术治疗肝硬化门静脉高压共识意见[J].临床肝胆病杂志,2014,30(3):210-213.

[14] WARD TJ,TECHASITH T,LOUIE JD,et al. Emergent salvage direct intrahepatic portocaval shunt procedure for acute variceal hemorrhage[J]. J Vasc Interv Radiol,2015,26(6):829-834.

[15] IMAI Y,NAKAZAWA M,ANDO S,et al. Long-term outcome of 154 patients receiving balloon-occluded retrograde transvenous obliteration for gastric fundal varices[J]. J Gastroenterol Hepatol,2016,31(11):1844-1850.

[16] JANG SY,KIM GH,PARK SY,et al. Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis:a retrospective multicenter study[J]. Clin Mol Hepatol,2012,18(4):368-374.

[17] GIMM G,CHANG Y,KIM HC,et al. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for the management of gastric variceal bleeding[J]. Gut Liver,2018,12(6):704-713.

[18] WANG YB,ZHANG JY,GONG JP,et al. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension:A meta-analysis[J]. J Gastroenterol Hepatol,2016,31(4):727-733.

[19] BENGMARK S,BRJESSON B,HOEVELS J,et al. Obliteration of eso PHTageal varices by PTP:A follow-up of 43 patients[J]. Ann Surg,1979,190(4):549-554.

[20] TIAN X,WANG Q,ZHANG C,et al. Modified percutaneous transhepatic variceal embolization with 2-octylcyanoacrylate for bleeding gastric varices:Long-term follow-up outcomes[J]. AJR Am J Roentgenol,2011,197(2):502-509.

[21] SAAD WEA,LIPPERT A,AAD NE,et al. Ectopic varices:anatomical classification,hemodynamic classification,and hemodynamic-based management[J]. Tech Vasc Interv Radiol,2013,16(2):108-125.

[22] HOUSE T,WEBB P,BAARSON C. Massive hemorrhage from ectopic duodenal varices:Importance of a multidisciplinary approach[J]. Case Rep Gastroenterol,2017,11(1):36-41.

[23] CHOI JW,KIM HC,JAE HJ,et al. Transcatheter embolotherapy with N-Butyl cyanoacrylate for ectopic varices[J]. Cardiovasc Intervent Radiol,2015,38(2):344-351.

[24] SATO T. Treatment of ectopic varices with portal hypertension[J]. World J Hepatol,2015,7(12):1601-1605.

[25] ZHAO R,LU J,SHI Y,et al. Current management of refractory ascites in patients with cirrhosis[J]. J Int Med Res,2018,46(3):1138-1145.

[26] Chinese Society of Hepatology,Chinese Medical Association.Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol,2017,33(10):1847-1863.(in Chinese)中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南[J].临床肝胆病杂志,2017,33(10):1847-1863.

[27] LUNGREN MP,KIM CY,STEWART JK,et al. Tunneled peritoneal drainage catheter placement for refractory ascites:Single-center experience in 188 patients[J]. J Vasc Interv Radiol,2013,24(9):1303-1308.

[28] PICCIRILLO M,RINALDI L,LEONGITO M,et al. Percutaneous implant of Denver peritoneo-venous shunt for treatment of refractory ascites:A single center retrospective study[J].Eur Rev Med Pharmacol Sci,2017,21(21):3668-3673.

[29] KIM MY,CHOI H,BAIK SK,et al. Portal hypertensive gastropathy:Correlation with portal hypertension and prognosis in cirrhosis[J]. Dig Dis Sci,2010,55(12):3561-3567.

[30] SALEEM K,BAIG FA,NIDA M,et al. Correlation between severity of portal hypertensive gastropathy and size of OesoPHTageal varices in cirrhotic hepatitis-C patients[J]. J Ayub Med Coll Abbottabad,2018,30(1):54-57.

[31] GARG H,GUPTA S,ANAND AC,et al. Portal hypertensive gastropathy and gastric antral vascular ectasia[J]. Indian J Gastroenterol,2015,34(5):351-358.

[32] SNYDER P,ALI R,POLES M,et al. Portal hypertensive gastropathy with a focus on management[J]. Expert Rev Gastroenterol Hepatol,2015,9(9):1207-1216.

[33] SONG T,RSSLE M,HE F,et al. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome:A systematic review and meta-analysis[J]. Dig Liver Dis,2018,50(4):323-330.

[34] GRADY K,GOWDA S,KINGAH P,et al. Coil embolization of pulmonary arteries as a palliative treatment of diffuse type I hepatopulmonary syndrome[J]. Respir Care,2015,60(2):e20-e25.

施引文献

资源附件(0)

访问统计